Smart Library
Faceted search across all 5 registries. Filter by registry type, evidence level, or safety domain.
New to hirudotherapy? Start here
This library indexes the full evidence base. For orientation, begin with the core guides:
Filters
Evidence level
Showing 26 of 730 entries. Refine via URL query params.
Conditions
26Venous Leg Ulcer
Tier BOff-label adjunct to compression therapy; the journal evidence is one 20-patient uncontrolled series in complicated varicose veins plus case reports; the books add an older report on trophic ulcers of unspecified origin (see “What the books describe” below).
Essential Hypertension (Adjunctive)
Tier CInvestigational adjunctive use with only non-randomized clinical reports identified; proposed mechanisms are blood-volume removal and hirudin effects on vessels; not a substitute for pharmacotherapy.
Hemorrhoids (Grade II-III, Symptomatic)
Tier CInvestigational use for symptomatic relief of grade II-III internal/external hemorrhoidal disease; does not address anatomic prolapse.
Glaucoma (Adjunctive)
Tier CInvestigational adjunctive use in primary open-angle glaucoma; weak case-series evidence. Not a substitute for IOP-lowering eye drops or surgery.
Sciatica (Non-Discogenic / Piriformis)
Tier CInvestigational use for non-discogenic sciatica including piriformis syndrome; no controlled trial, only an old unquantified Russian case series.
Plaque Psoriasis (Localized)
Tier CInvestigational adjunct, not a primary treatment; a few small, mostly uncontrolled studies report lower PASI scores.
Atopic Eczema (Localized Refractory)
Tier CInvestigational use for localized refractory eczema; evidence is limited to a few small studies without placebo or standard-care controls.
Keloid and Hypertrophic Scarring
Tier CInvestigational use for keloid and hypertrophic scars; evidence is limited to one small uncontrolled series and two conflicting single-patient reports.
Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
Tier CInvestigational for category III CP/CPPS: evidence is limited to a 3-patient case report, an uncontrolled Russian series and a comparison in urogenital infection; multimodal therapy remains standard.
Endometriosis-Related Pelvic Pain
Tier CInvestigational adjunctive use for chronic endometriosis-related pelvic pain; very limited evidence. Not a substitute for hormonal or surgical management.
Chronic Pelvic Pain Syndrome (Non-Specific)
Tier CInvestigational for non-specific chronic pelvic pain; the only clinical report located is an uncontrolled 60-woman series in which leeches were one part of multimodal care.
Subjective Tinnitus
Tier CInvestigational for tinnitus; small non-randomized studies, mostly Russian, report less ear noise, and no study using the Tinnitus Handicap Inventory was identified.
Carpal Tunnel Syndrome (Mild-Moderate)
Tier CInvestigational use for mild-to-moderate carpal tunnel syndrome; only one single-patient case report and one randomized-trial protocol without results were identified.
Severe Inflammatory Acne Vulgaris
Tier CHighly investigational use for severe nodulocystic acne refractory to isotretinoin; small Ayurvedic studies only, none in refractory disease, and scarring risk concerns.
Hypertrophic Scars
Tier CInvestigational adjunct for hypertrophic scars (within the original wound), distinct from keloid; evidence is one small uncontrolled Russian series.
Congestive Heart Failure (Compensated, Investigational Adjunct)
Tier CInvestigational adjunct in compensated NYHA II heart failure; only small open-label or uncontrolled studies were identified, mostly in Russian-language sources; guideline-directed medical therapy remains primary.
Post-Stroke Hemiplegia (Investigational Adjunct)
Tier CInvestigational adjunct to physical/occupational therapy in chronic post-stroke hemiplegia; no RCT support; not for acute stroke care.
Hashimoto's Thyroiditis (Investigational Cervical Adjunct)
Tier CHighly investigational adjunct in stable Hashimoto's thyroiditis; small uncontrolled series only; levothyroxine replacement remains primary.
Hepatic Portal Congestion (Non-Cirrhotic, Investigational)
Tier CHighly investigational adjunct for non-cirrhotic hepatic congestion; uncontrolled Russian series only; cirrhosis and portal hypertension are absolute exclusions.
Temporomandibular Joint Disorder (Investigational Adjunct)
Tier CInvestigational adjunct for chronic temporomandibular joint disorder; conservative care (education, jaw exercises, occlusal splint, NSAIDs) remains first-line; specialty referral for refractory cases.
Benign Prostatic Hyperplasia (Investigational Adjunct)
Tier CInvestigational adjunct for symptomatic benign prostatic hyperplasia; alpha-blockers, 5-alpha-reductase inhibitors, and minimally invasive surgical therapy remain evidence-based.
Endometrioma (Palliative Investigational Adjunct)
Tier CPalliative investigational adjunct for endometrioma-related chronic pelvic pain in patients declining or unable to undergo surgical/hormonal management.
Adenomyosis (Investigational Palliative Adjunct)
Tier CInvestigational palliative adjunct for adenomyosis-related dysmenorrhea and pelvic pain; hormonal therapy (LNG-IUD, dienogest, GnRH antagonists) and (definitively) hysterectomy remain evidence-based.
Sensorineural Hearing Loss (chronic) and Sudden Hearing Loss
Tier CNo randomized trial was found; a few small reports without described randomization or blinding mention less ear noise and some hearing gain in chronic loss. Sudden hearing loss is an emergency: urgent ENT care comes first, and leeches must never delay it.
Ankylosing Spondylitis Axial Pain (Investigational Adjunct)
Tier CInvestigational adjunct for axial pain in ankylosing spondylitis; NSAIDs, biologic DMARDs (TNF and IL-17 inhibitors), and structured exercise remain evidence-based first-line therapy.
Burning Mouth Syndrome (Investigational Adjunct)
Tier CInvestigational adjunct for primary burning mouth syndrome; clonazepam (topical or systemic), alpha-lipoic acid, low-dose tricyclics, and cognitive behavioral therapy remain evidence-based.